Peers are trading at AUD $3B for preclinical and AUD $4.95B for Phase I and Phase II, differences in cash balance aside.
Here's a comparison of efficacy and maturity of peers.
Ann: Compelling Preclinical Breast Cancer Results, page-52
-
- There are more pages in this discussion • 202 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
0.000(0.00%) |
Mkt cap ! $245.3M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 7201 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 160 | 1 |
View Market Depth
| Last trade - 09.44am 12/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |
Day chart unavailable